Insiders' View of Government
Online: May 8-June 24, 2017 | In-Person: May 22-25, 2017 | 3 credits
This institute is open to current graduate students at the George Washington University (GW), as well as visiting students (e.g., biomedical engineers, medical doctors, J.D. candidates and entrepreneurs in the life-science field) interested in drug and device development and the regulatory aspects of translational research.
This summer institute, in the nation’s capital, explores how innovative drugs and devices are developed and regulated. You will have the opportunity to:
- Visit the Food and Drug Administration (FDA) and the National Institute of Health (NIH),
- Listen to policy experts and thought leaders explain the ramifications of proposed regulatory initiatives, and
- Solve case studies with regulatory and quality professionals from around the world.
The course is an international, multi-disciplinary program organized by the GW School of Medicine and Health Sciences, the GW Law School, and the European Center of Pharmaceutical Medicine (ECPM) at the University of Basel, Switzerland.
By the end of the course, students will be able to:
- Describe how the current regulatory science framework affects the decision-making process for assessing the risks and benefits of medical products.
- Describe innovative research approaches in the field of regulatory science.
- Analyze the current healthcare climate and predict its influence on future health care initiatives.
- Identify regulatory strategies for product submissions and quality systems.
- Recognize new principles and methodological concepts of epidemiology and health economics and classify their impact on public health.
- 3-credit GW course: Tuition (3 credit hours - School of Medicine & Health Sciences) + $230 Program Fee
- Conference-Only Option: $1600
- Discounted Conference-Only Option: $950
- One-Day Conference Pass: $500
- You may choose any of the four days - see the conference agenda (PDF) for details.
Discounts are available to the following individuals who wish to attend the conference only:
- Academic: Available to those with a current full-time position at an educational institution.
- NGO's: Available to employees of registered NGO's only.
- Governmental organizations: Available to government employees.
- Advisory Boards Organizations: Available to those with a current full-time position at an organization, which has an employee serving in the Advisory Board of the Regulatory Affairs Master Program at GW, or in the Advisory Board of the Master of Medicines Development (MDD) at the University of Basel, Switzerland.
If you have questions about qualifying for the discounted price, please contact Ms. Melanie Trask at firstname.lastname@example.org.
Meet the Program Organizers & Participants
Dr. Daniela Drago, the institute’s program director, is an assistant professor and the director of the Regulatory Affairs Graduate Programs at the GW School of Medicine and Health Sciences.
Partners at ECPM, University of Basel
Dr. Thomas Szucs, is a professor in Pharmaceutical Medicine and Director of ECPM, University of Basel.
Dr. Annette Mollet, is the head of Education and Training at ECPM, University of Basel.
Partner at GW Law School
Dr. Neil Ruiz, is the Executive Director of the Center for Law, Economics, and Finance at GW Law School.
The institute will feature speakers from different areas of expertise.
To register, please contact Ms. Melanie Trask at email@example.com.
For further details, please visit the program page.